Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-074448
Filing Date
2021-05-28
Accepted
2021-05-28 20:35:53
Documents
1
Period of Report
2021-05-26

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2117938-5_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2117938-5_4seq1.xml 4 4163
  Complete submission text file 0001104659-21-074448.txt   5672
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Issuer) CIK: 0001509745 (see all company filings)

EIN.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O LEAP THERAPEUTICS, INC. 47 THORNDIKE STREET, SUITE B1-1 CAMBRIDGE MA 02141
Business Address
O'Mahony John Mark (Reporting) CIK: 0001808556 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37990 | Film No.: 21982510